The warning follows results from postmarketing observational studies that suggested a higher incidence of GBS within 42 days after vaccination, according to a Jan. 7 news release f.
GBS is a rare neurological disorder that causes weakened muscles and, in severe cases, paralysis due to immune system damage to nerve cells.
The FDA has recommended that healthcare professionals monitor patients for signs of GBS following vaccination. Both vaccine manufacturers are following events and effects.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
